Solutions lyophilization

Iduronidase solution lyophilized lysosomal enzymes purified from bovine testis (Moscerdam Substrates) are reconstituted in 2.2 ml demineralized water and aliquots are stored at -80°C. 

Preparative HPLC is another convenient method for isolating degradants from excipient compatibility matrices (72,73). The peaks from stressed samples can be collected, the solvent removed with a rotary evaporator, and the remaining solution lyophilized to obtain purified compounds. The samples can then be analyzed by other methods such as mass spectrometry and nuclear magnetic resonance (NMR) in order to identify the molecular composition. 

These enzymes must have a large activity spectrum, and ideally enantioselectivity for toxic stereoisomers. Their mass production under GMP conditions must be realizable at a reasonable cost. Long-term storage without activity loss (in solution, lyophilized, or adsorbed/bound on a matrix) must be possible under field conditions. Conformational stability can be optimized by chemical modification or addition of stabihzers such as polyols. Thermostable enzymes from thermophilic bacteria (Merone et al., 2005) or mutated/ evolved highly stable enzymes from mesophilic bacteria (Elias et al., 2008) are promising alternatives. 

Control material A device, solution, lyophilized preparation, or pool of collected human or animal specimen, or artificially derived material, intended for use in the quality control process. ... 

The labeling reaction should be followed by reverse-phase HPLC and compared with the control solutions. Dual-wavelength monitoring is often helpful with fluorescent labels. Upon confirming that the labeling reaction was successful, purify the labeled PNA immediately. Otherwise, freeze the solution, lyophilize (in the dark if the label is light sensitive), and store the dried material at — 20°C until purification can be performed. 

Lyophilization. LyophiLization is essentially a drying technology. Some dmgs and biologicals are thermolabile and/or unstable in aqueous solution. Utilization of freeze drying permits the production of granules or powders that can be reconstituted by the addition of water, buffered solution, or mixed hydrophilic solvents just prior to use, eg, certain antibiotic suspensions. 

Clinical Use. Vancomycin and teicoplanin as fomiulated dmgs are lyophilized powders to be reconstituted with sterile water for injection. Vancomycin hydrochloride [1404-93-9] is presented in vials of 500 mg that give 100—200 mL solution of pH 2.5—4.2. It is administered by slow (60 min) infusion at a dose of 500 mg every 6 h or 1 g every 12 h/d. The teicoplanin contains the five factors (87%) plus 13% of the pseudoaglycone T-A3-1. It is presented in vials containing 200 mg of lyophili ed power that after dissolution with 3 mL of solvent gives a solution at pH 7.5. The dose regimen is 200—800 mg/d by iv bolus adrninistration. 

Kits. Kits for the preparation of radiopharmaceuticals are a convenient solution to synthesis of products containing short-Hved radionucHdes (eg, In, I, Tc) bound to a nonradio active moiety. The labeling step is performed either at a commercial radiopharmacy, or within the institutional nuclear medicine laboratory. The kits are usually stored as a frozen solution or lyophilized product. The material of interest is then metered out into kit dosages. The kit vials are thawed or reconstituted and mixed with the appropriate radionucHde. 

Drying is an operation in which volatile Hquids are separated by vaporization from soHds, slurries, and solutions to yield soHd products. In dehydration, vegetable and animal materials are dried to less than their natural moisture contents, or water of crystallization is removed from hydrates. In freeze drying (lyophilization), wet material is cooled to freeze the Hquid vaporization occurs by sublimation. Gas drying is the separation of condensable vapors from noncondensable gases by cooling, adsorption (qv), or absorption (qv) (see also Adsorption, gas separation). Evaporation (qv) differs from drying in that feed and product are both pumpable fluids. 

Two complexes of FeCl, with NH OH were received in crystalline state-one-brown by precipitation from the solution (HI) and pink-brown compound was received by lyophilic drying of the solution (IV). 

To this solution was added at one time the above-obtained ethyl acetate solution at -15°C, and the resulting mixture was stirred for 1 hour at -10°C to -15°C. The reaction mixture was cooied to -30°C, and water (80 ml) was added thereto. The aqueous layer was separated, adjusted to pH 4.5 with sodium bicarbonate and subjected to column chromatography on Diaion HP-20 resin (Mitsubishi Chemical Industries Ltd.) using 25% aqueous solution of isopropyl alcohol as an eluent. The eluate was lyophilized to give 7-[2-methoxyimino-2-(2-amino-1,3-thiazol-4-yl)acetamido] cephalosporanic acid (syn isomer) (1.8 g), MP 227°C (decomp.). 

A slight excess of a 10% sodium hydroxide solution was added to a solution of 23 grams of silver nitrate in 300 cc of water. The precipitated silver oxide was washed free of silver ion with distilled water. To a suspension of the silver oxide in 200 cc of water, a solution of 25 grams of (3-hydroxyphenyl)ethyl dimethylammonium iodide in 300 cc of water was added. The precipitate of silver iodide was removed by filtration and the filtrate concentrated to a volume of about 100 cc In vacuo. The remainder of the water was removed by lyophilization. (3-hydroxyphenyl)ethyl dimethylammonium hydroxide was obtained as a hygroscopic, amorphous solid,... 

The soiution was treated with 0.01 mol of formaldehyde in aqueous solution, with agitation. The solution was then filtered to eliminate traces of insoluble product and the filtrate was lyophilized. Sodium 6-[ D(-)-alpha-(methylene-amino-phenylacetamido)] -penicillanate was obtained. 

To a solution of 5 g of sisomicin in 250 ml of water add 1 N sulfuric acid until the pH of the solution is adjusted to about 5. To the solution of sisomicin sulfuric acid addition salt thereby formed, add 2 ml of acetaldehyde, stir for 10 minutes, then add 0.B5 g of sodium cyanoborohydride. Continue stirring at room temperature for 15 minutes, then concentrate solution In vacuo to a volume of about 100 ml, treat the solution with a basic ion exchange resin [e.g., Amberlite IRA401S (OH )], then lyophilize to a residue comprising 1-N-ethyl-sisomicin. 

Sterile agar slants are prepared using the Streptomyces sporulation medium of Hickey and Tresner, J. Bact., vol. 64, pages 891-892 (1952). Four of these slants are inoculated with lyophilized spores of Streptomyces antibioticus NRRL 3238, incubated at 28°C for 7 days or until aerial spore growth is well-advanced, and then stored at 5°C. The spores from the four slants are suspended in 40 ml of 0.1% sterile sodium heptadecyl sulfate solution. A nutrient medium having the following composition is then prepared 2.0% glucose monohydrate 1.0% soybean meal, solvent extracted, 44% protein 0.5% animal peptone (Wilson s protopeptone 159) 0.2% ammonium chloride 0.5% sodium chloride 0.25% calcium carbonate and water to make 100%. 

Further development of the chromatogram with 0.1N ammonia afforded fractions positive to ninhydrin test. From the fractions, 249 mg. of a colorless material was obtained. It was dissolved in 19 ml. of water and the solution was adjusted to pH 4.0 with dilute hydrochloric acid. A colorless material, after condensing under a reduced pressure and lyophilization, was recrystallized from aqueous methanol with a small amount... 

N-Acetylation of Kasugamycinic Acid (9a). A solution of kasugamycinic acid (225 mg.) dissolved in 10 ml. of water was treated with acetic anhydride (0.3 ml.) under cooling sodium bicarbonate was used to keep the pH 7.2 and stirring continued for 30 minutes. The reaction product was passed through Dowex 50W-X2 (H form) and the column was washed with water. The combined filtrate was subjected to lyophilization to afford 234 mg. of a crude N-acetyl derivative. Its infrared spectrum showed strong absorptions at 1740 cm-1 characteristic of oxamic acid group. The N-acetyl derivative (178 mg.) was treated with 40 ml. 

Oxidation of C9-Amine (3) with Lead Tetraacetate. C9-Amine hydrochloride (53 mg., 0.17 mmole) was dissolved in 0.1 ml. of water and 5 ml. of acetic acid and to the solution was added lead tetraacetate (190 mg., 0.3 mmole) at 16°-18°C. in 10 minutes. Insoluble material was removed by filtration, and the filtrate was dried by lyophilization. The residue was dissolved in 5 ml. of water and the solution was placed on a column of Amberlite CG-50 (ammonium form, 1 x 10 cm.) followed by a similar treatment as described in the case of periodate oxidation. N-Cyano derivative (5.1 mg.) was obtained and proved to be identical with the N-cyano derivative obtained from the periodate oxidation. 

---